SCHEMBL19683687

SCHEMBL19683687

Brc1oc2c(ccc3c2ccc2c(-c4ccccc4)c(Br)oc23)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.40
CYP1A2 P05177 6/20 0.40
CYP1B1 Q16678 6/20 0.40
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
MAPT P10636 4/20 0.35
MAPK1 P28482 4/20 0.35
KDM4E B2RXH2 4/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
RECQL P46063 1/20 0.35
ERAP1 Q9NZ08 1/20 0.35
ALDH1A1 P00352 5/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11365381 0.87 CYP1A1 (0.50) CYP1A1CYP1A2CYP1B1MAPTMAPK1
SCHEMBL11545707 0.80 MAOB (0.44) CYP1A1CYP1A2CYP1B1MAPTMAPK1
SCHEMBL11705784 0.77 CYP1A2 (0.35) CYP1A2CDK5MAPTMAPK1KDM4E
SCHEMBL10259424 0.77 ALDH1A1 (0.52) CYP1A1CYP1A2CYP1B1CDK1CCNB1
SCHEMBL11559370 0.76 KMT2A (0.36) MAPTMAPK1KDM4ETDP1L3MBTL1
SCHEMBL11623919 0.76 DHODH (0.49) MAPTKDM4ETDP1GAAALDH1A1
SCHEMBL11663639 0.75 CA1 (0.49) CYP1B1MAPTMAPK1KDM4ETDP1
SCHEMBL11551571 0.73 PDCD1 (0.35) CYP1A2CDK5MAPTMAPK1KDM4E
SCHEMBL9925463 0.73 CDK1 (0.39) CYP1A1CYP1A2CYP1B1CDK1CCNB1
SCHEMBL11554775 0.73 MAOB (0.48) CYP1A1CYP1A2CYP1B1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304595-A1 Electroactive Compounds LG CHEM, LTD. (KR) 2025-10-02 US disclosed
WO-2017210072-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304595-A1 Electroactive Compounds NAT1, NES, SULT1E1 CYP1A1 140/4885CYP1A2 901/4885CYP1B1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.